Profusa (PFSA) Change in Accured Expenses (2022 - 2026)
Profusa posted quarterly Change in Accured Expenses of $65000.0 for Q1 2026, down 52.21% year-on-year from $136000.0 in Q1 2025, and down 98.21% on a QoQ basis from $3.6 million in Q4 2025.
Profusa (PFSA) has 5 years of Change in Accured Expenses data on file, last reported at $65000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses fell 52.21% year-over-year to $65000.0; the trailing twelve-month figure through Mar 2026 stood at $4.4 million (up 156.1% YoY), and the FY2025 full-year result was $522000.0, down 68.63% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $65000.0, down from $3.6 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $3.6 million in Q4 2025 and bottomed at -$35990.0 in Q2 2023.
- The 5-year median for Change in Accured Expenses is $51461.0 (2023), against an average of $369159.1.
- The widest annual swing landed in 2023, when Change in Accured Expenses sank 258.57%; it then surged 11760.0% in 2024.
- A 5-year view of Change in Accured Expenses shows it stood at $15000.0 in 2022, then plunged by 133.33% to -$5000.0 in 2023, then soared by 11760.0% to $583000.0 in 2024, then soared by 521.61% to $3.6 million in 2025, then sank by 98.21% to $65000.0 in 2026.
- The last three Change in Accured Expenses figures came in at $65000.0 (Q1 2026), $3.6 million (Q4 2025), and $136000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Profusa | 574,294.01 | 574,294.01 | - | 65,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65,000.00 |
| Mar 31, 2026 | 65,000.00 |
| Dec 31, 2025 | -5.40 Mn |
| Dec 31, 2025 | -5.40 Mn |
| Dec 31, 2024 | 583,000.00 |
| Dec 31, 2024 | 583,000.00 |
| Sep 30, 2024 | 825,283.00 |
| Sep 30, 2024 | 825,283.00 |
| Jun 30, 2024 | 90,544.00 |
| Jun 30, 2024 | 90,544.00 |
| Mar 31, 2024 | 165,173.00 |
| Mar 31, 2024 | 165,173.00 |
| Dec 31, 2023 | 36,438.00 |
| Dec 31, 2023 | 36,438.00 |
| Sep 30, 2023 | 10,023.00 |
| Sep 30, 2023 | 10,023.00 |
| Jun 30, 2023 | -36,461.00 |
| Jun 30, 2023 | -36,461.00 |
| Mar 31, 2023 | 15,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Dec 31, 2022 | -192,513.00 |
| Dec 31, 2022 | -192,513.00 |
| Sep 30, 2022 | 192,077.00 |
| Sep 30, 2022 | 192,077.00 |
| Jun 30, 2022 | 43,133.00 |
| Jun 30, 2022 | 43,133.00 |
| Mar 31, 2022 | -19,310.00 |
| Mar 31, 2022 | -19,310.00 |